Economy & Business
A bigger RNA role for Rochester
|
GreenLight Biosciences’ $16.6 million manufacturing plant at Eastman Business Park will provide the agriculture industry with targeted biocontrols that attack destructive pests.
Economy & Business
An entrepreneur who stayed true to his vision
|
Klaus Gueldenpfennig, who died Friday at 85, founded Redcom Laboratories with his wife, Brigitte, and built an able competitor in a field dominated by far-larger firms.
Culture
Hula-ers of hoop
|
This year’s Fringe Festival opener of “Cirque de Fringe: Afterparty” had all jaws in attendance dropping.
Justice & Public Safety
PAB seeks independence from City Council
|
Rochester’s Police Accountability Board wants the ability to hire staffers, negotiate salaries and carry out other administrative functions.
Justice & Public Safety
The scourge of illegal guns
|
The U.S. is awash in guns, and a number of them end up on the street as crime weapons. In Rochester, law enforcement and nonprofits are grappling with the problem.
Events
How will Malik Evans lead Rochester?
|
After his landslide Democratic primary win, Malik Evans has a clear path to becoming Rochester’s next mayor. In an Oct. 12 online event with the Rochester Beacon, Evans will discuss his priorities and vision for the city.
Health & Science
Researcher warns of fracking dangers
|
Elaine Hill, a public health economist at the University of Rochester Medical Center, co-authored an article in the journal Science that calls for tighter regulation.
Four Questions
A local economic first responder
|
Tompkins Bank of Castile processed more than 1,300 Payroll Protection Program loans. President and CEO John McKenna. He thinks community banks like his can help small firms and nonprofits get through the current pandemic surge.
Culture
Vintage vibrations from Levitation Room
|
The L.A. rockers, now on their first East Coast tour, will play the Bug Jar tonight.
Economy & Business
State program focused on pandemic resilience opens
|
Eligible startups and early-stage companies and academic institutions can apply for grants from the $40 million Biodefense Commercialization Fund.